Yield10 Bioscience Generates Revenue from Camelina Seed Genetics to Biofuel Platform

Yield10 Bioscience, an agricultural bioscience company, has announced a significant milestone in its “Camelina Seed Genetics to Biofuel” platform. The company has successfully completed the harvest of a majority of the winter and spring Camelina sativa grain produced under grower contracts for the 2022/2023 season. The harvested grain is being delivered to an offtake partner, where it is crushed and refined into biofuel, marking the establishment of Yield10’s revenue-generating phase.

The achievement of generating revenue from Camelina grain delivery for biofuel production is a crucial step for Yield10. The company expects this revenue stream to become a key contributor to its financial profile in the coming years. Yield10’s President and CEO, Oliver Peoples, expressed his satisfaction with this milestone and credited the commitment and dedication of the Yield10 team and their grower partners for the accomplishment.

With the successful commercialization of the “Camelina Seed Genetics to Biofuel” platform, Yield10 can now focus on building the technology foundation to accelerate grower adoption of Camelina for the biofuels market. The company believes that its herbicide-tolerant Camelina varieties, currently in development and regulatory review, will play a vital role in expanding acreage substantially over time.

Yield10’s primary goal for 2023 was to demonstrate the commercial aspects of its value chain, including engaging growers, signing grower contracts, and facilitating timely grain offtake for biofuel production. This milestone showcases the company’s capabilities in building strong commercial relationships, executing logistics, and driving revenue generation. It also positions Camelina as a potential major source of low-carbon index feedstock oil for the biofuel industry.

The feedback from growers who participated in planting winter and spring Camelina has been positive, particularly in areas affected by drought conditions. Yield10 is actively working to secure grower contracts for the third quarter of 2024 and encourages potential growers to contact the company to learn more about participating in the “Camelina Seed Genetics to Biofuel” platform.

Yield10 continues to engage with market participants to secure additional partnerships in the biofuel space. The company’s headquarters are located in Woburn, Massachusetts, with a subsidiary in Saskatoon, Canada.

Yield10 Bioscience’s successful revenue generation from its Camelina grain delivery for biofuel production marks a significant step towards its vision for sustainable seed products. With its innovative approach and commitment to advancing agricultural bioscience, Yield10 is poised to make a positive impact on the biofuel industry and contribute to a more sustainable future.